GMT EIGHT - Announcement

Beijing Emerging Eastern Aviation Equipment (002933.SZ) Director and General Manager Xiang Ziqi has reduced his holdings by a total of 96,000 shares.

Beijing Emerging Eastern Aviation Equipment (002933.SZ) announcement: The company's director and general manager, Mr. Xiang Ziqi, has cumulatively reduced his company's shareholding by 96,000 shares, and the reduction plan has been completed.

21/02/2025

Realcan Pharmaceutical Group (002589.SZ) plans to invest 151 million yuan to acquire 76.01% equity of Zhejiang Hengjiu.

Realcan Pharmaceutical Group (002589.SZ) announced that its subsidiary, Jixiangshan (Shandong) Medical Technology Co., Ltd., intends to acquire 76.01% equity of Zhejiang Hengjiu Medical Devices Co., Ltd. (referred to as "Zhejiang Hengjiu") from the related party Yantai Hengyue Health Technology Partnership Enterprise (Limited Partnership) ("Yantai Hengyue") in cash. The valuation of the investment target Zhejiang Hengjiu is 199 million yuan, and the transaction amount for 76.01% equity of Zhejiang Hengjiu in this transaction is 151 million yuan (subject to adjustments based on performance commitments). It is reported that Zhejiang Hengjiu was established on November 1, 2017, and its main products include innovative medical devices such as a three-dimensional breast ultrasound tomography imaging system. The three-dimensional breast ultrasound tomography imaging system is a semi-spherical breast ultrasound tomography imaging system, which features three modal images (ultrasound gray scale image, sound velocity image, and sound attenuation coefficient image) that do not rely on the experience of doctors, fast data collection, quick imaging, and automation. It has high specificity and sensitivity in medical clinical applications and is an innovative product for early detection and screening of breast cancer. As of the date of this announcement, Zhejiang Hengjiu has applied for 59 related patents, with 45 of them already authorized and 10 invention patents. This transaction aligns with Realcan Pharmaceutical Group's overall strategy of industry layout around the health industry upstream and downstream. It is a key step in expanding into the field of medical device production and research and development, in line with the company's transformation direction. The existing hospital channels of the company and the core competitiveness of Zhejiang Hengjiu's breast detection equipment can form a good synergy. Zhejiang Hengjiu's products are currently in the clinical research stage, with product development finalized, and the subsequent risks of registration and listing are substantially controllable. Completing the acquisition at this stage can leverage the company's existing hospital channels to advance academic communication and market layout for the product, and rapidly commercialize sales once the product registration certificate is approved. In addition, the integration of both research and development teams can maximize resource efficiency.

21/02/2025

Shandong Sanyuan Biotechnology's shareholder, Lu Xin Capital, plans to reduce its stake by no more than 3%.

Shandong Sanyuan Biotechnology (301206.SZ) announced that its shareholder Shandong Lixin Qisheng Investment Management Co., Ltd.- Shandong Lixin Capital Market Development Equity Investment Fund (Limited Partnership) ("Lixin Capital") plans to reduce its shareholding in the company by a total of no more than 6,037,200 shares (i.e. no more than 3% of the total share capital excluding the shares held in the company's repurchase special securities account) through centralized bidding and block trading within 3 months after the date of this announcement (March 17, 2025 to June 16, 2025), starting from 15 trading days after the date of this announcement.

21/02/2025

Some directors and senior executives of Hangzhou Cable (603618.SH) plan to reduce their holdings by a total of no more than 2.9335 million shares.

Hangzhou Cable (603618.SH) announced that the company's directors, supervisors, and senior management Hu Jianfei, Lu Chunxiao, Ni Yijian, Yin Zhiping, and Hu Jianming plan to collectively reduce their holdings of the company's shares by no more than 2.9335 million shares.

21/02/2025

Hunan Xiangjia Animal Husbandry (002982.SZ) shareholder Da Jing Shuangjia's reduced holding period expires, with a total reduction of 2.39% of shares.

Announcement from Hunan Xiangjia Animal Husbandry (002982.SZ): The deadline for the share reduction plan of the company's shareholder, Da Jing Shuangjia, has expired. The total number of shares reduced by the shareholder is 3.47 million shares, with a reduction ratio of 2.3941%.

21/02/2025

Shareholders Fuxin Investment and Zhongkai Investment of Jiamei Food Packaging (002969.SZ) plan to reduce their shareholding by no more than 1%.

Announcement by Jiamei Food Packaging (002969.SZ): Shareholders Fuxin Investment Co., Ltd. (referred to as "Fuxin Investment") and Zhongkai Investment Development Co., Ltd. (referred to as "Zhongkai Investment") plan to collectively reduce their holdings of the company's shares by no more than 9.5485 million shares (1% of the total share capital of the company) through centralized bidding trading from March 17, 2025 to June 16, 2025.

21/02/2025

Domestic business growth slowed down, Hangzhou Hikvision Digital Technology (002415.SZ) saw a 15.23% decrease in net profit for the 2024 fiscal year, dropping to 11.959 billion yuan.

Hangzhou Hikvision Digital Technology (002415.SZ) disclosed its performance report for the year 2024. The company achieved a total operating revenue of 92.486 billion yuan, an increase of 3.52% compared to the same period last year; the net profit attributable to the shareholders of the listed company was 11.959 billion yuan, a decrease of 15.23% compared to the same period last year; and the basic earnings per share were 1.295 yuan. The announcement stated that in 2024, the company's domestic business growth rate declined, while the overseas market continued to grow steadily.

21/02/2025

Sangfor Technologies Inc. (300454.SZ) reported a net profit of 197 million yuan in 2024, a decrease of 0.49% year-on-year.

Sangfor Technologies Inc. (300454.SZ) released its 2024 annual performance report. During the reporting period, the company achieved operating income of about 7.52 billion yuan, a decrease of 1.86% year-on-year, mainly due to the weak demand from domestic industry clients, leading to a decline in the company's revenue. The net profit attributable to the shareholders of the listed company was 1.97 billion yuan, a decrease of 0.49% year-on-year.

21/02/2025

Shanghai W-Ibeda High Tech. Group (688071.SH) plans to launch an employee stock ownership plan in 2025.

Shanghai W-Ibeda High Tech.Group (688071.SH) disclosed the 2025 employee stock ownership plan (draft), with the proposed number of target stocks to be held by the company's employee stock ownership plan not exceeding 306,893 shares, accounting for approximately 0.36% of the total capital stock of 84,789,724 shares at the time of the announcement of the employee stock ownership plan draft. The price at which the employee stock ownership plan purchases the target stocks in the company's repurchase special account is 19.52 yuan/share. The participants in the employee stock ownership plan include the company's directors (excluding independent directors), supervisors, senior management personnel, and key business and technical personnel of the company. The total number of holders at the initial establishment of the employee stock ownership plan shall not exceed 14 persons. The term of the employee stock ownership plan is 38 months, starting from the date of the announcement of the last transfer of the target stocks to the employee stock ownership plan. The target stocks obtained through the employee stock ownership plan are unlocked in two phases, with unlocking points at 12 months and 24 months from the last transfer of the target stocks to the employee stock ownership plan, with a distribution of 50% of the target stocks for each unlocking period.

21/02/2025

Qinghai Salt Lake Industry (000792.SZ): The total shareholding proportion of China Salt Lake and its concerted action party Anji Investment will change to 21.89%.

Qinghai Salt Lake Industry (000792.SZ) announced that China Minmetals, Qinghai Provincial State-owned Assets Supervision and Administration Commission, Qinghai Guotou, and China Salt Lake (the controlling shareholder of the company) have recently signed an agreement on the 100% equity investment in Qinghai Huixin Asset Management Co., Ltd. (referred to as "Huixin Company"). Qinghai Provincial State-owned Assets Supervision and Administration Commission will make a capital contribution to China Salt Lake with its 100% equity in Huixin Company. After this investment is completed, Huixin Company will become a wholly-owned subsidiary of China Salt Lake. Huixin Company directly holds 1.34% of Qinghai Salt Lake Industry's shares. After the equity changes, China Salt Lake and its concerted action person, ICBC Investment, directly and indirectly hold a total of 21.89% of the listed company's shares, and China Salt Lake's controlling shareholder and actual controller, China Minmetals, directly and indirectly hold a total voting rights of 25.30% of the listed company. The stability of the listed company's controlling rights is further strengthened.

21/02/2025

Contact: contact@gmteight.com